VYNE Therapeutics Inc. Gains 25.28%
VYNE Therapeutics Inc. (VYNE:NASDAQ) rocketted at $5.6, a gain of 25.3%. On Wed, Apr 26, 2023, VYNE:NASDAQ hit a New 2-Week High of $5.6. The stock got featured on our News Catalysts scanner on Wed, Apr 19, 2023 at 09:06 AM in the 'BIOTECH' category. From Wed, Apr 12, 2023, the stock recorded 70.00% Up Days and 81.82% Green Days
The stock spiked on Tue, Jan 10, 2023 at $6.88 with a volume of 1M+.
About VYNE Therapeutics Inc. (VYNE:NASDAQ)
VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology.
Top 10 Gainers:
- Elevation Oncology Inc. (ELEV:NASDAQ), 77.19%
- Etao International Co. Ltd. (ETAO:NASDAQ), 57.33%
- SAI.TECH Global Corp Cl A Ord (SAI:NASDAQ), 34.05%
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 34.01%
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 33.33%
- Intuitive Machs Inc Cl A (LUNR:NASDAQ), 32.28%
- Beasley Broadcast Group, Inc. (BBGI:NASDAQ), 26.56%
- TDH Holdings, Inc. (PETZ:NASDAQ), 25.77%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 25.28%
- VCI Global Limited (VCIG:NASDAQ), 24.74%